Background and Aim: Coronavirus disease (COVID-19) has been announced as a life-threatening, highly transmissible infectious novel emerging disease worldwide. Rapid detection and epidemiological information are desperately needed to overcome the existing pandemic situation and alleviate national and international crises. Still, to date, there is no significant epidemiological study of COVID-19 available in Bangladesh, especially in the Chattogram division. However, the current study focuses on molecular detection, prevalence, and risk factors associated with COVID-19 in Southern Bangladesh. Materials and Methods: Standard diagnostic protocols through real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) were performed for molecular confirmation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Different patient demographics were analyzed for exploring the relationship of four factors – region, sex, age, and symptoms with the accumulated number of COVID-19 cases in the Southern Bangladesh during the period of May 13, 2020, to June 12, 2020. Results: A total of 2954 samples were tested where the cumulative prevalence of circulating SARS-CoV-2 was 29.76% (n=879; 95% CI: 28.11-31.44) in the selected study region. Among the risk factors, the present study revealed that flatland people (35.62%, 95% CI 33.61-37.67, OR=3.13) were more vulnerable to getting infected by SARS-CoV-2 than the people living in hill tracts (13.04%, 95% CI 10.73-15.63). People older than 50 years (34.68%, 95% CI 30.38-39.18) were designated the highest risk than other different age groups. A higher number of COVID-19 cases were confirmed in patients (36.0%, 95% CI 33.77-38.29, OR=1.76) with typical symptoms, but interestingly a significant number of asymptomatic carriers (20.39%, 95% CI 18.13-22.80) also positive for SARS-CoV-2. Conclusion: To the best of our knowledge, this is the first epidemiological report in the Southern Bangladesh for COVID- 19. The study's findings will contribute to health professionals and the policy-makers to take preventive measures against the next outbreak emergency for Bangladesh.
Background: Acute pancreatitis (AP) is a frequent cause for hospitalization. However, molecular determinants that modulate severity of experimental pancreatitis are only partially understood.Objective: To investigate the role of secreted protein acidic and rich in cysteine (SPARC) during cerulein-induced AP in mice.Methods: AP was induced by repeated cerulein injections in SPARC knock-out mice (SPARC −/− ) and control littermates (SPARC +/+ ). Secreted protein acidic and rich in cysteine expression and severity of AP were determined by histopathological scoring, immunohistochemistry, and biochemical assays. For functional analysis, primary murine acinar cell cultures with subsequent amylase release assays were employed. Proteome profiler assay and ELISA were conducted from pancreatic tissue lysates, and co-immunofluorescence was performed.Results: Upon cerulein induction, SPARC expression was robustly induced in pancreatic stellate cells (PSCs) but not in acinar cells. Genetic SPARC ablation resulted in attenuated severity of AP with significantly reduced levels of pancreatic necrosis, apoptosis, immune cell infiltration, and reduced fibrosis upon chronic stimulation. However, the release of amylase upon cerulein stimulation in primary acinar cell culture from SPARC +/+ and SPARC −/− was indistinguishable. Notably, immune cell derived C-C Motif Chemokine Ligand 2 (CCL2) was highly elevated in SPARC +/+ pancreatic tissue potentially linking PSC derived SPARC with CCL2 induction in AP. Conclusion: SPARC mediates the severity of AP. The potential link between SPARC and the CCL2 axis could open new avenues for tailored therapeutic interventions in AP patients and warrants further investigations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.